Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes side effects, interactions and indications.
Prescribing information from Gilead.
U.S. Food and Drug Administration Approves Gilead’s Sovaldi (Sofosbuvir)
Press release from Gilead about the approval of their drug Sovaldi for the treatment of Chronic Hepatitis C. (December 06, 2013)
Last update:June 20, 2016 at 0:42:56 UTC